amplitude 发表于 2025-3-28 15:01:25

http://reply.papertrans.cn/71/7014/701379/701379_41.png

共栖 发表于 2025-3-28 21:46:01

Chronic Myelogenous Leukemiar-abl inhibitor, namely imatinib mesylate (Gleevec, STI-571) [.]. As a results of these events, CML became the first human neoplasm in which the rationally designed therapeutic agent to target the carcinogenic pathway demonstrated clinical efficacy.

发芽 发表于 2025-3-28 23:33:17

http://reply.papertrans.cn/71/7014/701379/701379_43.png

orient 发表于 2025-3-29 03:50:56

http://reply.papertrans.cn/71/7014/701379/701379_44.png

很像弓] 发表于 2025-3-29 10:11:44

http://reply.papertrans.cn/71/7014/701379/701379_45.png

Osteoporosis 发表于 2025-3-29 13:37:23

Y. Oh,V. Papadimitrakopoulou. Vor allem die Ausführungen zu wichtigen Weaningstrategien nehmen Bezug auf die S2k-Leitlinie zum prolongierten Weaning. Ein praxisnahes Werk mit zahlreichen Tipps und Fallbeispielen..978-3-662-49795-1

斑驳 发表于 2025-3-29 16:19:53

http://reply.papertrans.cn/71/7014/701379/701379_47.png

neologism 发表于 2025-3-29 21:27:57

A Probabilistic Approach to Organic Component Detection in Leishmania Infected Microscopy Imagesnic component detection is performed through adaptive segmentation using a two-level Otsu’s Method. Two probabilistic classifiers then analyze the detected regions, as to how many components may constitute each one. The first of these employs rule-based reasoning centered on the decreasing harmonic

Angiogenesis 发表于 2025-3-30 01:36:36

Digital Technology in Mathematics Education: Past Performance and Future Pathways,sketches the scene for digital technology in mathematics education. Section 17.2 addresses the book and in particular addresses the straddle between the past and the future, between the practice and the research orientation, that is manifest throughout the chapters and characterizes the transition p

LUCY 发表于 2025-3-30 05:00:01

http://reply.papertrans.cn/71/7014/701379/701379_50.png
页: 1 2 3 4 [5] 6 7
查看完整版本: Titlebook: Oncologic Therapies; Everett E. Vokes,Harvey M. Golomb Book 2003Latest edition Springer-Verlag Berlin Heidelberg 2003 Cancer therapy.Chemo